Schedule 13G ownership disclosure

ENTASIS THERAPEUTICS HLDGS I

Security class unavailable · CUSIP: 293614103

Event date: 2020-08-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-20-216367
Form type
SC 13G/A
Filer
Entasis Therapeutics Holdings Inc.
CIK
CIK 1724344
Filed
Aug 11, 2020
Reporting period
Aug 06, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub